Diverticular disease and gut microbiota modulation: a focus on probiotics

Posted on by adminLeave a comment

Prof. O.I. Sergienko, assoc.prof. A.I. Chernobai, asp. G.Yu. Tegelska, assос.prof. A.I. Novokhatnya,  assос.prof. Yu.K. Sikalo

Kharkiv National Medical University, Department of therapy, gastroenterology and dieteti

The article presents a modern description of the phenotypes of diverticular disease.

The risk factors of diverticular disease, the features of the course of the disease and the ethical role of the intestinal microbiota are highlighted.

The feasibility of using probiotics and metabiotics based on short-chain fatty acids, butyrate and inulin in the treatment of diverticular disease is substantiated.

Key words: diverticular disease, microbiota, probiotics, metabiotics

https://doi.org/10.15407/internalmed2026.01.087

Download.PDF (ukr)

Cite:

Сергієнко, О.І. Дивертикулярна хвороба та модуляція кишкової мікробіоти: акцент на пробіотичні засоби / О.І. Сергієнко, А.І. Чернобай, Г.Ю. Тегельська, А.Є. Новохатня, Ю.К. Сікало // Східноєвропейський журнал внутрішньої та сімейної медицини. — 2026. — № 1. — С. 87-91. doi: 10.15407/internalmed2026.01.087

Sergienko OI, Chernobai AI, Tegelska GYu, Novokhatnya AI, Sikalo YuK. Dyvertykuliarna khvoroba ta moduliatsiia kyshkovoi mikrobioty: aktsent na probiotychni zasoby [Diverticular disease and gut microbiota modulation: a focus on probiotics]. Shidnoevr. z. vnutr. simejnoi med. 2026;1:87-91. Ukrainian. doi: 10.15407/internalmed2026.01.087

References:

  1. Humes D, Lewis-Lloyd C. Diverticular disease. Medicine. 2024;52(5):279-283. https://doi.org/10.1016/j.mpmed.2024.02.006

  2. Williams S, Bjarnason I, Hayee B, Haji A. Diverticular disease: update on pathophysiology, classification and management. Frontline Gastroenterol. 2024;15(1):50-58. https://doi.org/10.1136/flgastro-2022-102361

  3. Kishnani S, Ottaviano K, Rosenberg L, et al. Diverticular Disease-An Updated Management Review. Gastroenterol Insights. 2022;13(4):326-339. https://doi.org/10.3390/gastroint13040032

  4. Peery AF, Shaukat A, Strate LL. AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review. Gastroenterology. 2021;160(3):906-911.e1. https://doi.org/10.1053/j.gastro.2020.09.059

  5. Strate LL, Morris AM. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156(5):1282-1298.e1. https://doi.org/10.1053/j.gastro.2018.12.033

  6. Francis NK, Sylla P, Abou-Khalil M, et al. EAES and SAGES 2018 consensus conference on acute diverticulitis management: evidence-based recommendations for clinical practice. Surg Endosc. 2019;33:2726-2741. https://doi.org/10.1007/s00464-019-06882-y

  7. Tursi A. Current and Evolving Concepts on the Pathogenesis of Diverticular Disease. J Gastrointestin Liver Dis. 2019;28:225-223. https://doi.org/10.15403/jgld-184

  8. Coakley KM, Davis BR, Kasten KR. Complicated Diverticular Disease. Clin Colon Rectal Surg. 2021;34(2):96-103. https://doi.org/10.1055/s-0040-1716701

  9. Zviahintseva TD, Chernobai AI. Metabolichno-asotsiiovana zhyrova khvoroba pechinky ta mikrobiota kyshechnyka: patohenetychni vzaiemozv’iazky ta terapevtychni misheni [Metabolic-associated fatty liver disease and intestinal microbiota: pathogenic relationships and therapeutic targets]. Skhidnoievropeiskyi medychnyi zhurnal vnutrishnikh khvorob ta simeinoi medytsyny. 2023;(2):4-11. Ukrainian. https://doi.org/10.15407/internalmed2023.02.004

  10. Hanna MH, Kaiser AM. Update on the management of sigmoid diverticulitis. World J Gastroenterol. 2021;27:760-781. https://doi.org/10.3748/wjg.v27.i9.760

  11. Tursi A, Elisei W. Role of Inflammation in the Pathogenesis of Diverticular Disease. Mediators Inflamm. 2019;2019:8328490. https://doi.org/10.1155/2019/8328490

  12. Barbaro MR, Cremon C, Fuschi D, et al. Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation. Int J Mol Sci. 2022;23:6698. https://doi.org/10.3390/ijms23126698

  13. Ishiguro Y, Kuriyama A, Ishiguro S. Diverticular perforation with exclusive local invasion in cytomegalovirus infection during ganciclovir treatment: an autopsy case report. Ann Med Surg (Lond). 2025;87(9):6083-6087. https://doi.org/10.1097/MS9.0000000000000357

  14. Humphrey HN, Sibley P, Walker ET. Genetic, epigenetic and environmental factors in diverticular disease: systematic review. BJS Open. 2024;8(3):zrae032. https://doi.org/10.1093/bjsopen/zrae032

  15. Bohm SK, Kruis W. Lifestyle and other risk factors for diverticulitis. Minerva Gastroenterol Dietol. 2017;63(2):110-118. https://doi.org/10.23736/S1121-421X.17.02371-6

  16. Hall J, Hardiman K, Lee S, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis. Dis Colon Rectum. 2020;63(6):728-747. https://doi.org/10.1097/DCR.0000000000001679

  17. Schultz JK, Azhar N, Binda GA, et al. European Society of Coloproctology: Guidelines for the management of diverticular disease of the colon. Colorectal Dis. 2020;22(Suppl 2):S5-S28. https://doi.org/10.1111/codi.15140

  18. Imaeda H, Hibi T. The Burden of Diverticular Disease and Its Complications: West versus East. Inflamm Intest Dis. 2018;3(2):61-68. https://doi.org/10.1159/000492178

  19. Piscopo N, Ellul P. Diverticular Disease: A Review on Pathophysiology and Recent Evidence. Ulster Med J. 2020;89(2):83-88.

  20. Rezapour M, Ali S, Stollman N. Diverticular Disease: An Update on Pathogenesis and Management. Gut Liver. 2018;12(2):125-132. https://doi.org/10.5009/gnl16552

  21. Violi A, Cambiè G, Miraglia C, et al. Epidemiology and risk factors for diverticular disease. Acta Biomed. 2018;89(9-S):107-112. https://doi.org/10.23750/abm.v89i9-S.7924

  22. Tănase I, Păun S, Stoica B, et al. Epidemiology of diverticular disease – systematic review of the literature. Chirurgia (Bucur). 2015;110(1):9-14.

  23. Strate LL, Mody R, Cohen E, Spiegel B. Diverticular disease as a chronic condition: new epidemiologic and clinical data. Am J Gastroenterol. 2012;107(10):1486-1493. https://doi.org/10.1038/ajg.2012.194

  24. Krokowicz L, Stojcev Z, Kaczmarek BF, et al. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis – a prospective randomized study. Int J Colorectal Dis. 2014;29(3):387-393. https://doi.org/10.1007/s00384-013-1807-5

  25. Canani RB, Costanzo MD, Leone L, et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17(12):1519-1528. https://doi.org/10.3748/wjg.v17.i12.1519

  26. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care. 2012;15(5):474-479. https://doi.org/10.1097/MCO.0b013e32835665fa